Business Wire

GIGABYTE

14.4.2020 11:02:06 CEST | Business Wire | Press release

Share
New GIGABYTE Laptops Win 2020 Red Dot Design Awards

The leading personal computer brand, GIGABYTE, recently received the 2020 Red Dot Design Award for two creator laptops from the AERO line – AERO 15 OLED & AERO 17 – as well as two professional gaming laptops – AORUS 15G and AORUS 17X. The recognition further establishes GIGABYTE’s role as a market leader in the laptop industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200414005017/en/

There were over 6,500 entries from 60 countries contending in this year’s Red Dot Design Awards. GIGABYTE is committed to producing the AERO Creator Laptop and AORUS Gaming Laptop lines in Taiwan. With their ultra-slim bezel, Xrite Pantone color calibration, Microsoft Azure AI, and other industry leading technologies, GIGABYTE’s laptops have already been recognised with the European Hardware Awards for Best Notebook as well as receiving Taiwan Excellence Awards. The notebooks are now honored with the 2020 Red Dot Design Award.

AORUS: Redefining Gaming Laptops

AORUS laptops are fast and powerful, with screens that offer a high refresh rate coupled with exceptional mechanical keyboards. In 2020, AORUS takes it further by collaborating with G2 Esports, a professional global esports team, to develop a purpose-built gaming laptop that caters to professional gamer’s needs. The comprehensive and integrative design concept was crucial for GIGABYTE in winning the award.

The product design is infused with a sense of extreme performance, with the flagship AORUS 17X being inspired by super cars and a fighter jet. The chassis is created using CNC (Computer Numerical Control) technology, carving the all-aluminum chassis into a robust frame with defined angles. RGB LED lights are scattered from end to end showcasing the flagship laptop’s overwhelming speed and power.

The second winning laptop, the brand new AORUS 15G, is a professional gaming laptop for on-the-road gamers: though also equipped with a mechanical keyboard, the AORUS 15G is lighter and has a longer lasting battery. The design of AORUS 15G was also inspired by sports cars with the side of the chassis embellished with faux race car features to create a feel of extreme sports while adding a touch of minimalist modernism.

AERO: An Equilibrium of Performance and Mobility

The aesthetic of the creator laptops in the AERO line are inspired by science fiction films. The full aluminum chassis is finished with NIL (Nano-Imprint Lithography), presenting superior quality that is simple but by no means underwhelming. Steven Chen, VP of GIGABYTE’s Mobile Business Center, stated that the beauty of AERO laptops lies in “more possibilities” and therefore they must have lighter bodies, long-lasting batteries, and great performance without any compromise due to overheating.

The AERO line is well-balanced in many aspects, visual artist Rus Khasonov was inspired by AERO to create videos with the AERO 15 OLED, “With AERO, I can render with After Effects and edit with Photoshop at the same time. I’m deeply impressed that such a light body can offer such performance.”

The full line of creator laptops from AERO, including the 15” AERO 15 OLED and 17” AERO 17 HDR with 4K monitors as well as the AERO 15 and AERO 17 with FHD monitors, are available starting on 16th April. The graphics card powerhouse, NVIDIA, is upping the prize for creators and has promised free access to Adobe Creative Cloud for three months to anyone buying the RTX Studio equipped models. For details, please refer to the official website: https://www.gigabyte.com/Laptop

- ENDS -

About GIGABYTE

GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.

Link:

ClickThru

Social Media:

https://www.facebook.com/GIGABYTE.Notebook.Global/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye